| Literature DB >> 22044070 |
Kirsi Tamminen1, Leena Huhti, Tiia Koho, Suvi Lappalainen, Vesa P Hytönen, Timo Vesikari, Vesna Blazevic.
Abstract
Norovirus (NoV) -derived virus-like particles (VLPs) resemble empty shells of the virus and NoV P-particles contain only protruding domains of the NoV capsid. Both NoV-derived subviral particles show similar functionality and antigenicity in vitro and are considered to be potential vaccine candidates against NoV gastroenteritis. BALB/c mice were immunized with baculovirus-produced GII-4 VLPs or the corresponding Escherichia coli-produced P-particles by the intramuscular or intradermal route and the NoV-specific antibody and T-cell immune responses were compared. Elevated antibody levels were induced with a single VLP immunization, whereas P-particle immunization required a boost. High avidity antibodies were raised only by VLP immunization. VLP immunization resulted in a balanced T helper type 1/type 2 immune response whereas P-particles induced a T helper type 2-biased response. Only VLP immunization primed T cells for interferon-γ production. Most importantly, cross-reactive B and T cells were induced solely by VLP immunization. In addition, VLP antiserum blocked the binding of heterotypic VLPs to human histo-blood group antigen receptor and saliva. The findings in this study are relevant for the development of NoV vaccines.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22044070 PMCID: PMC3246655 DOI: 10.1111/j.1365-2567.2011.03516.x
Source DB: PubMed Journal: Immunology ISSN: 0019-2805 Impact factor: 7.397